$72.83
1.351.89%
At close: -
$72.83
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Biomarin Pharmaceutical Earnings Estimates, EPS & Revenue | NASDAQ:BMRN | Benzinga
Biomarin Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 23
EPS Estimate
$0.870
Quarterly Revenue Estimate
$723.51M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.85B
Analyze the earnings history of Biomarin Pharmaceutical using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical | $0.71 | $0.87 | — | — | $648.83M | $723.51M | — | — | 04/23/2025 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.49 | $0.74 | $0.92 | 24.32% | $646.21M | $711.05M | $747.00M | 5.06% | 02/19/2025 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.46 | $0.52 | $0.91 | 75.00% | $581.33M | $700.14M | $745.74M | 6.51% | 10/29/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.54 | $0.35 | $0.96 | 174.29% | $595.27M | $661.23M | $712.03M | 7.68% | 08/05/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.60 | $0.34 | $0.71 | 108.82% | $596.41M | $651.79M | $648.83M | -0.45% | 04/24/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.00 | $0.23 | $0.49 | 113.04% | $537.54M | $636.67M | $646.21M | 1.50% | 02/22/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.04 | $0.22 | $0.46 | 109.09% | $505.34M | $608.33M | $581.33M | -4.44% | 11/01/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.15 | $0.47 | $0.54 | 14.89% | $533.80M | $591.46M | $595.27M | 0.65% | 07/31/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.63 | $0.18 | $0.60 | 233.33% | $519.36M | $570.62M | $596.41M | 4.52% | 04/26/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.32 | -$0.07 | $0.00 | 100.00% | $449.81M | $536.97M | $537.54M | 0.11% | 02/27/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.20 | -$0.01 | -$0.04 | -300.00% | $408.74M | $518.91M | $505.34M | -2.61% | 10/26/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.07 | $0.11 | $0.59 | 436.36% | $501.69M | $521.47M | $533.80M | 2.36% | 08/03/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.09 | — | $0.17 | — | $486.03M | $507.52M | $519.36M | 2.33% | 04/27/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.12 | -$0.32 | -$0.32 | 0.00% | $452.12M | $442.39M | $449.81M | 1.68% | 02/23/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $4.01 | -$0.25 | -$0.20 | 20.00% | $476.78M | $435.32M | $408.74M | -6.11% | 10/27/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.16 | -$0.11 | $0.07 | 163.64% | $429.49M | $448.79M | $501.69M | 11.79% | 07/28/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.44 | -$0.10 | $0.09 | 190.00% | $502.07M | $446.45M | $486.03M | 8.87% | 04/29/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.08 | -$0.19 | $0.12 | 163.16% | $454.44M | $440.23M | $452.12M | 2.70% | 02/25/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.30 | $1.29 | $4.01 | 210.85% | $461.10M | $454.64M | $476.78M | 4.87% | 11/05/2020 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.29 | -$0.11 | -$0.16 | -45.45% | $387.76M | $418.61M | $429.49M | 2.60% | 08/04/2020 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.32 | $0.05 | $0.44 | 780.00% | $400.75M | $468.77M | $502.07M | 7.10% | 04/29/2020 | Get Alert |
Biomarin Pharmaceutical (BMRN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-19 | $0.92 | $0.74 | 24.3 % |
| Q3 | 2024-10-29 | $0.91 | $0.52 | 75.0 % |
| Q2 | 2024-08-05 | $0.96 | $0.35 | 174.3 % |
| Q1 | 2024-04-24 | $0.71 | $0.34 | 108.8 % |
Biomarin Pharmaceutical (BMRN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-19 | $747.00M | $711.05M | 5.06 % |
| Q3 | 2024-10-29 | $745.74M | $700.14M | 6.51 % |
| Q2 | 2024-08-05 | $712.03M | $661.23M | 7.68 % |
| Q1 | 2024-04-24 | $648.83M | $651.79M | -0.45 % |
FAQ
When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
Biomarin Pharmaceutical (BMRN) is scheduled to report earnings on April 23, 2025. The last reported earnings were for reported on February 19, 2025 for Q4.
What were the latest earnings per share (EPS) for Biomarin Pharmaceutical (NASDAQ:BMRN)?
The Actual EPS was $0.92, which beat the estimate of $0.74.
What were Biomarin Pharmaceutical’s (NASDAQ:BMRN) revenues?
The Actual Revenue was $747M, which beat the estimate of $711M.
Browse earnings estimates, EPS, and revenue on all stocks.